Patents by Inventor Ryan Bonvillain

Ryan Bonvillain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230174947
    Abstract: Described herein are methods and compositions for use in improving a vascular barrier of endothelial cells. The methods may include the use of barrier agonist compounds and improved techniques for culturing endothelial cells. The improved methods and compositions for culturing endothelial cells may include at least one or more of the following: an adenylyl cyclase activator; an activator of Sphingosine-1-phosphate (S1P) receptor internalization; a direct or indirect inducer of tight junction protein expression, and a direct or indirect inducer of adherens junction protein expression.
    Type: Application
    Filed: December 7, 2022
    Publication date: June 8, 2023
    Applicant: United Therapeutics Corporation
    Inventors: Bryan Fioret, Thomas Petersen, Ryan Bonvillain, David Graham, Peter Vu, Lotte van den Goor
  • Publication number: 20200352157
    Abstract: An automated bioreactor system for decellularizing an organ includes a main chamber for containing the organ. The system further includes a reagent chamber containing a liquid phase reagent. A reagent conduit delivers the liquid phase reagent to the main chamber, and a perfusion conduit delivers the reagent from the reagent outlet in the main chamber into the organ. A perfusion pump drives the flow of the reagent. A perfusion pressure sensor detects a pressure of the flowing reagent. A control system controls the perfusion pump to drive the flow of the reagent based on a received input representative of a desired pressure and a received input of the detected pressure. The control system may automatically perform all of the steps of a decellularization protocol based on sensor input. An automated waste decontamination system may also be provided.
    Type: Application
    Filed: July 29, 2020
    Publication date: November 12, 2020
    Applicant: United Therapeutics Corporation
    Inventors: Ryan Bonvillain, John Cheadle, Thomas Petersen
  • Patent number: 10757932
    Abstract: An automated bioreactor system for decellularizing an organ includes a main chamber for containing the organ. The system further includes a reagent chamber containing a liquid phase reagent. A reagent conduit delivers the liquid phase reagent to the main chamber, and a perfusion conduit delivers the reagent from the reagent outlet in the main chamber into the organ. A perfusion pump drives the flow of the reagent. A perfusion pressure sensor detects a pressure of the flowing reagent. A control system controls the perfusion pump to drive the flow of the reagent based on a received input representative of a desired pressure and a received input of the detected pressure. The control system may automatically perform all of the steps of a decellularization protocol based on sensor input. An automated waste decontamination system may also be provided.
    Type: Grant
    Filed: September 1, 2015
    Date of Patent: September 1, 2020
    Assignee: UNITED THERAPEUTICS CORPORATION
    Inventors: Ryan Bonvillain, John Cheadle, Thomas Peterson
  • Publication number: 20180228144
    Abstract: An automated bioreactor system for decellularizing an organ includes a main chamber for containing the organ. The system further includes a reagent chamber containing a liquid phase reagent. A reagent conduit delivers the liquid phase reagent to the main chamber, and a perfusion conduit delivers the reagent from the reagent outlet in the main chamber into the organ. A perfusion pump drives the flow of the reagent. A perfusion pressure sensor detects a pressure of the flowing reagent. A control system controls the perfusion pump to drive the flow of the reagent based on a received input representative of a desired pressure and a received input of the detected pressure. The control system may automatically perform all of the steps of a decellularization protocol based on sensor input. An automated waste decontamination system may also be provided.
    Type: Application
    Filed: September 1, 2015
    Publication date: August 16, 2018
    Applicant: United Therapeutics Corporation
    Inventors: Ryan Bonvillain, John Cheadle, Thomas Peterson